The phylogeny of osteopontin—Analysis of the protein sequence

International Journal of Molecular Sciences

Volumn 19, Issue 9, 2018, Pages

  Weber, Georg F ^a  

^a UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

Author keywords

Evolution; Osteopontin; Protein; Sequence; Taxonomy

Indexed keywords

CASEIN KINASE I; CASEIN KINASE II; CATHEPSIN D; CYCLINE; MATRILYSIN; OSTEOPONTIN; PLASMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; STROMELYSIN; THROMBIN; INTEGRIN; LIPOPROTEIN LIPASE; PROTEIN BINDING;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; CALCIUM HOMEOSTASIS; CELLULAR IMMUNITY; GENE EXPRESSION; GENE MUTATION; ISOELECTRIC POINT; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENETIC TREE; PHYLOGENY; PLANT TAXONOMY; PROTEIN MOTIF; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; WHOLE GENOME SEQUENCING; CHEMISTRY; GENETICS; METABOLISM; POSITION WEIGHT MATRIX; PROTEIN DOMAIN;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; INTEGRINS; LIPOPROTEIN LIPASE; OSTEOPONTIN; PHYLOGENY; POSITION-SPECIFIC SCORING MATRICES; PROTEIN BINDING; PROTEIN DOMAINS; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 85052643955     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19092557     Document Type: Article

References (34)

1. Liaw, L.; Birk, D.E.; Ballas, C.B.; Whitsitt, J.S.; Davidson, J.M.; Hogan, B.L. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Investig. 1998, 101, 1468–1478.
2. Rittling, S.R.; Matsumoto, H.N.; McKee, M.D.; Nanci, A.; An, X.R.; Novick, K.E.; Kowalski, A.J.; Noda, M.; Denhardt, D.T. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 1998, 13, 1101–1111.
3. Denhardt, D.T.; Noda, M.; O’Regan, A.W.; Pavlin, D.; Berman, J.S. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Investig. 2001, 107, 1055–1061.
4. Ashkar, S.; Weber, G.F.; Panoutsakopoulou, V.; Sanchirico, M.E.; Janssen, M.; Zawaideh, S.; Rittling, S.; Denhardt, D.T.; Glimcher, M.J.; Cantor, H. Eta-1 (Osteopontin): An early component of type 1 (cell-mediated) immunity. Science 2000, 287, 860–864.
5. Shiraga, H.; Min, W.; van Dusen, W.J.; Clayman, M.D.; Miner, D.; Terrell, C.H.; Sherbotie, J.R.; Foreman, J.W.; Przysiecki, C.; Neilson, E.G.; et al. Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc. Natl. Acad. Sci. USA 1992, 89, 426–430.
6. Schack, L.; Lange, A.; Kelsen, J.; Agnholt, J.; Christensen, B.; Petersen, T.E.; Sørensen, E.S. Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas. J. Dairy Sci. 2009, 92, 5378–5385.
7. Weber, G.F.; Lett, G.S.; Haubein, N.C. Osteopontin is a marker for cancer aggressiveness and patient survival. Br. J. Cancer 2010, 103, 861–869.
8. Weber, G.F.; Lett, G.S.; Haubein, N.C. Meta-analysis of Osteopontin as a clinical cancer marker. Oncol. Rep. 2011, 25, 433–441.
9. Adler, B.; Ashkar, S.; Cantor, H.; Weber, G.F. Costimulation through adhesion molecules determines the response to ligation of the T-cell antigen receptor. Cell. Immunol. 2001, 210, 30–40.
10. Prince, C.W.; Dickie, D.; Krumdieck, C.L. Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem. Biophys. Res. Commun. 1991, 177, 1205–1210.
11. Sørensen, E.S.; Rasmussen, L.K.; Møller, L.; Jensen, P.H.; Højrup, P.; Petersen, T.E. Localization of transglutaminase-reactive glutamine residues in bovine osteopontin. Biochem. J. 1994, 304, 13–16.
12. Shinohara, M.L.; Kim, H.J.; Kim, J.H.; Garcia, V.A.; Cantor, H. Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc. Natl. Acad. Sci. USA 2008, 105, 7235–7239.
13. Zduniak, K.; Ziolkowski, P.; Ahlin, C.; Agrawal, A.; Agrawal, S.; Blomqvist, C.; Fjällskog, M.L.; Weber, G.F. Nuclear osteopontin-c is a prognostic breast cancer marker. Br. J. Cancer 2015, 112, 729–738.
14. He, B.; Mirza, M.; Weber, G.F. An osteopontin splice variant induces anchorage independence in human breast cancer. Oncogene 2006, 25, 2192–2202.
15. Weber, G.F.; Zawaideh, S.; Kumar, V.A.; Glimcher, M.J.; Cantor, H.; Ashkar, S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J. Leukoc. Biol. 2002, 72, 752–761.
16. Cao, Z.; Dai, J.; Fan, K.; Wang, H.; Ji, G.; Li, B.; Zhang, D.; Hou, S.; Qian, W.; Zhao, J.; et al. Novel functional motif of osteopontin for human lymphocyte migration and survival. Mol. Immunol. 2008, 45, 3683–3692.
17. Sharma, Y.D. Genomic organization, structure and possible function of histidine-rich proteins of malaria parasites. Int. J. Biochem. 1988, 20, 471–477.
18. Pal, P.; Daniels, B.P.; Oskman, A.; Diamond, M.S.; Klein, R.S.; Goldberg, D.E. Plasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis. MBio 2016, 7, e00617–e00616.
19. Bayless, K.J.; Davis, G.E. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin. J. Biol. Chem. 2001, 276, 13483–13489.
20. 1 binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J. Biol. Chem. 1999, 274, 36328–36334.
21. 3-Integrin. J. Biol. Chem. 2012, 287, 3788–3797.
22. Kauffman, S.A. The Origins of Order. Self-Organization and Selection in Evolution; Oxford University Press: New York, NY, USA; Oxford, UK, 1993.
23. Graphodatsky, A.S.; Trifonov, V.A.; Stanyon, R. The genome diversity and karyotype evolution of mammals. Mol. Cytogenet. 2011, 4, 22.
24. Briones-Orta, M.A.; Avendaño-Vázquez, S.E.; Aparicio-Bautista, D.I.; Coombes, J.D.; Weber, G.F.; Syn, W.K. Osteopontin splice variants and polymorphisms in cancer progression and prognosis. Biochim. Biophys. Acta 2017, 1868, 93–108.
25. AlSarkhi, L.K.; Weber, G.F. Auto-antibodies to Osteopontin can arise in cancer. 2018, sumbit.
26. Crisp, A.; Boschetti, C.; Perry, M.; Tunnacliffe, A.; Micklem, G. Expression of multiple horizontally acquired genes is a hallmark of both vertebrate and invertebrate genomes. Genome Biol. 2015, 16, 50.
27. Suh, A.; Witt, C.C.; Menger, J.; Sadanandan, K.R.; Podsiadlowski, L.; Gerth, M.; Weigert, A.; McGuire, J.A.; Mudge, J.; Edwards, S.V.; et al. Ancient horizontal transfers of retrotransposons between birds and ancestors of human pathogenic nematodes. Nat. Commun. 2016, 7, 11396.
28. Bai, W.L.; Yang, R.J.; Yin, R.H.; Jiang, W.Q.; Luo, G.B.; Yin, R.L.; Zhao, S.J.; Li, C.; Zhao, Z.H. Molecular characterization and expression analysis of osteopontin cDNA from lactating mammary gland in yak (Bos grunniens). Mol. Biol. Rep. 2012, 39, 3627–3635.
29. Sivakumar, S.; Niranjali Devaraj, S. Tertiary structure prediction and identification of druggable pocket in the cancer biomarker—Osteopontin-c. J. Diabetes Metab. Disord. 2014, 13, 13.
30. Zhang, D.J.; Liu, D. Cloning and Expression Analysis of Wild Boar Osteopontin Gene. In Proceedings of the 3rd International Conference on Bioinformatics and Biomedical Engineering, Beijing, China, 11–13 June 2009; pp. 1–4.
31. Fonseca, V.G.; Laizé, V.; Valente, M.S.; Cancela, M.L. Identification of an osteopontin-like protein in fish associated with mineral formation. FEBS J. 2007, 274, 4428–4439.
32. Jones, D.T.; Taylor, W.R.; Thornton, J.M. The rapid generation of mutation data matrices from protein sequences. Comput. Appl. Biosci. 1992, 8, 275–282.
33. Kumar, S.; Stecher, G.; Tamura, K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 2016, 33, 1870–1874.
34. Frith, M.C.; Saunders, N.F.W.; Kobe, B.; Bailey, T.L. Discovering sequence motifs with arbitrary insertions and deletions. PLoS Comput. Biol. 2008, 4, e1000071.